Gimv NV (LON:0EKR)
London · Delayed Price · Currency is GBP · Price in EUR 43.60
+0.05 (0.11%)
At close: Dec 18, 2025
Gimv NV Revenue
Gimv NV had revenue of 157.05M EUR in the half year ending September 30, 2025, a decrease of -22.74%. This brings the company's revenue in the last twelve months to 270.68M, down -1.93% year-over-year. In the fiscal year ending March 31, 2025, Gimv NV had annual revenue of 300.94M with 3.07% growth.
Revenue (ttm)
270.68M EUR
Revenue Growth
-1.93%
P/S Ratio
6.02
Revenue / Employee
2.88M EUR
Employees
94
Market Cap
1.42B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 300.94M | 8.98M | 3.07% |
| Mar 31, 2024 | 291.96M | 294.38M | - |
| Mar 31, 2023 | -2.42M | -254.68M | - |
| Mar 31, 2022 | 252.27M | -78.75M | -23.79% |
| Mar 31, 2021 | 331.02M | 183.75M | 124.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |